Literature DB >> 19734053

Potential vascular actions of 2-methoxyestradiol.

Raghvendra K Dubey1, Edwin K Jackson.   

Abstract

2-Methoxyestradiol (2-ME) is a biologically active metabolite of 17beta-estradiol that appears to inhibit key processes associated with cell replication in vitro. The molecule has been suggested to have potent growth-inhibitory effects on proliferating cells, including smooth muscle cells and endothelial cells, and may be antiangiogenic. Because of these potential roles for 2-ME, its lack of cytotoxicity and low estrogenic activity, we hypothesize that 2-ME could be a valuable therapeutic molecule for prevention and treatment of cardiovascular diseases. Whether 2-ME is as effective in vivo as it is in vitro at modulating vascular processes remains controversial. Here we discuss recent developments regarding mechanisms by which 2-ME might regulate vascular activity and angiogenesis and speculate on the therapeutic implications of these developments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734053      PMCID: PMC2761235          DOI: 10.1016/j.tem.2009.04.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  50 in total

1.  2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.

Authors:  S P Tofovic; R K Dubey; E K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

2.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice.

Authors:  R H Karas; J B Hodgin; M Kwoun; J H Krege; M Aronovitz; W Mackey; J A Gustafsson; K S Korach; O Smithies; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice.

Authors:  J B Hodgin; J H Krege; R L Reddick; K S Korach; O Smithies; N Maeda
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.

Authors:  R H Karas; H Schulten; G Pare; M J Aronovitz; C Ohlsson; J A Gustafsson; M E Mendelsohn
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

Review 5.  Cardiovascular protective effects of 17beta-estradiol metabolites.

Authors:  R K Dubey; E K Jackson
Journal:  J Appl Physiol (1985)       Date:  2001-10

6.  Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.

Authors:  M R Robinson; J Baffi; P Yuan; C Sung; G Byrnes; T A Cox; K G Csaky
Journal:  Exp Eye Res       Date:  2002-02       Impact factor: 3.467

7.  Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.

Authors:  R K Dubey; D G Gillespie; L C Zacharia; M Rosselli; K R Korzekwa; J Fingerle; E K Jackson
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

8.  Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.

Authors:  Federica Barchiesi; Edwin K Jackson; Delbert G Gillespie; Lefteris C Zacharia; Juergen Fingerle; Raghvendra K Dubey
Journal:  Hypertension       Date:  2002-04       Impact factor: 10.190

9.  Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells.

Authors:  L C Zacharia; E K Jackson; D G Gillespie; R K Dubey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

10.  Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol.

Authors:  Yu Gui; Xi-Long Zheng; Jie Zheng; Michael P Walsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-05       Impact factor: 4.733

View more
  28 in total

1.  Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

Authors:  Federica Barchiesi; Eliana Lucchinetti; Michael Zaugg; Omolara O Ogunshola; Matthew Wright; Markus Meyer; Marinella Rosselli; Sara Schaufelberger; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages.

Authors:  Thikryat Neamatallah; Ashraf B Abdel-Naim; Basma G Eid; Atif Hasan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-07       Impact factor: 3.000

3.  Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.

Authors:  Christopher M Masi; Louise C Hawkley; John T Cacioppo
Journal:  Lipids       Date:  2011-08-02       Impact factor: 1.880

4.  2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.

Authors:  Lisa Rigassi; Federica Barchiesi Bozzolo; Eliana Lucchinetti; Michael Zaugg; Jürgen Fingerle; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson; Raghvendra K Dubey
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

Review 5.  Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.

Authors:  Svetlana Verenich; Phillip M Gerk
Journal:  Mol Pharm       Date:  2010-10-21       Impact factor: 4.939

6.  Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.

Authors:  Brett L Jennings; Joseph A Moore; Ajeeth K Pingili; Anne M Estes; Xiao R Fang; Alie Kanu; Frank J Gonzalez; Kafait U Malik
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-18

7.  Importance of estrogen metabolites.

Authors:  Sarah H Lindsey
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

8.  Estrogen metabolism by cytochrome P450 1B1 modulates the hypertensive effect of angiotensin II in female mice.

Authors:  Brett L Jennings; L Watson George; Ajeeth K Pingili; Nayaab S Khan; Anne M Estes; Xiao R Fang; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2014-04-28       Impact factor: 10.190

9.  2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia.

Authors:  Miriam Pertegal; Francisco J Fenoy; Barbara Bonacasa; Jaime Mendiola; Juan L Delgado; Moises Hernández; Miguel G Salom; Vicente Bosch; Isabel Hernández
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

10.  2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor.

Authors:  Sivaramakrishna Koganti; Russell Snyder; Upendra Gumaste; Vardan T Karamyan; Thomas Thekkumkara
Journal:  Eur J Pharmacol       Date:  2013-11-18       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.